QLC7401
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for QLC7401, covering 2024-12-27 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C) [Phase 3]